Global X Management Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$67K Buy
878
+356
+68% +$23K ﹤0.01% 1049
2018
Q1
$27K Buy
522
+22
+4% +$1.11K ﹤0.01% 1096
2017
Q4
$23K Buy
500
+127
+34% +$6.23K ﹤0.01% 1019
2017
Q3
$20K Buy
373
+11
+3% +$652 ﹤0.01% 1066
2017
Q2
$22K Buy
362
+29
+9% +$1.75K ﹤0.01% 1135
2017
Q1
$23K Buy
+333
New +$25.4K ﹤0.01% 1049

Other funds holding RARE

Global X Management Company's RARE Position: Q2 2018 in Review

Global X Management Company increased its Ultragenyx Pharmaceutical (RARE) stake by 68% in Q2 2018, buying an estimated $23K and bringing the position to 878 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Global X Management Company first reported a position in RARE in Q1 2017 and has held it in 6 quarters since. 158 funds tracked by Wall St. Rank hold RARE as of Q2 2018.

  • Global X Management Company held 878 shares of Ultragenyx Pharmaceutical worth $67K as of Q2 2018.
  • Global X Management Company bought 356 Ultragenyx Pharmaceutical shares in Q2 2018, an estimated $23K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1049 holding.
  • Global X Management Company first reported a position in Ultragenyx Pharmaceutical in Q1 2017 and has held it in 6 quarters since.
  • 158 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.